Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Progyny Sees FY23 Revenue $1.087B-$1.095B Vs $1.08B Est

Author: Benzinga Newsdesk | November 07, 2023 05:41pm

The Company is providing the following financial guidance for both the full year and three-month period ending December 31, 2023:

Full Year 2023 Outlook:
- Revenue is now projected to be $1,087 million to $1,095 million, reflecting growth of 38% to 39%
- Net income is projected to be $58.3 million to $60.0 million, or $0.58 to $0.59 per diluted share, on the basis of approximately 101 million assumed weighted-average fully diluted-shares outstanding
- Adjusted EBITDA1 is projected to be $186.0 million to $188.5 million

Posted In: PGNY